Evidence-led peptide reference
MOTS-C research guide
Updated 10 October 2026 · Editorial standards
A mitochondria-derived peptide studied as a signal linking cellular stress and energy metabolism.
Identity and context
What is MOTS-C?
MOTS-C is a short peptide encoded within the mitochondrial 12S ribosomal RNA region. That makes it part of a growing class of mitochondria-derived peptides: small signalling molecules linked to communication between mitochondria and the rest of the cell.
It should not be reduced to a simple “energy peptide.” Mitochondrial stress responses are interconnected with nutrient sensing, inflammation, insulin signalling and gene regulation, and experimental findings depend heavily on the model used.
Mechanism under investigation
How is MOTS-C studied?
Research suggests MOTS-C can influence folate and methionine metabolism, AMP-activated protein kinase (AMPK) and stress-responsive nuclear gene expression. AMPK is a cellular energy sensor, but activating or associating with this pathway does not automatically establish a performance or weight-loss effect in humans.
Some studies describe movement of MOTS-C to the nucleus during metabolic stress. This supports a signalling role between mitochondrial state and cellular adaptation, an area still being mapped.
Research map
Main areas of interest
Metabolic flexibility
Preclinical work examines glucose use, insulin sensitivity, fat metabolism and adaptation to nutrient stress.
Exercise biology
Studies investigate natural MOTS-C responses, skeletal-muscle signalling and associations with exercise capacity.
Ageing and stress
Research explores whether mitochondrial peptide signalling changes with age and contributes to resilience under cellular stress.
Strength of evidence
What does the evidence actually show?
Evidence is separated by level because a cell experiment, an animal model, a human trial and a regulatory decision answer different questions.
Critical reading
Limitations and unanswered questions
- Natural circulating associations do not prove that administering synthetic material recreates a beneficial response.
- Mouse metabolic findings frequently fail to translate directly to humans.
- Long-term human safety and clinically meaningful outcomes remain uncertain.
- Sequence identity and measured content are separate from sterility and endotoxin testing.
Analytical context
What a certificate of analysis can—and cannot—tell you
A certificate of analysis is a report about the particular submitted sample and tests named on that report. It can help document identity, measured amount or purity when suitable methods were used. It does not prove that every batch is identical, that a material is sterile or endotoxin-free, that it is clinically effective, or that it is approved for human use.
No product-specific COA is currently linked to this guide. Absence of a displayed report should not be interpreted as analytical verification.
Learn how to read a peptide COA →Questions answered
MOTS-C FAQs
Is MOTS-C made by mitochondria?
Its sequence is encoded within mitochondrial DNA and it is classed as a mitochondria-derived peptide.
What is AMPK?
AMPK is a cellular energy-sensing enzyme involved in responses to low-energy conditions and metabolic stress.
Is MOTS-C proven to improve exercise performance?
No. Interesting preclinical and associative findings do not establish a safe or effective performance treatment.
Is MOTS-C an approved medicine?
No. It remains an experimental research compound.
Primary and authoritative reading
Sources and further reading
Sources are provided so readers can inspect the underlying literature and current official information. Inclusion does not mean every claim in a paper has been independently confirmed.
- Original MOTS-C mechanistic study ↗Primary 2015 study using cell and mouse models; it does not establish a treatment effect in humans.
- MOTS-C mechanisms review ↗Peer-reviewed review of mitochondrial and metabolic mechanisms.
- PubMed MOTS-C literature ↗Current indexed research results.
Source and wording review: 7 October 2026. Prepared with AI assistance; no independent clinical review is claimed. Read the editorial policy or suggest a correction.